Search For "biological e"
BE's PNEUBEVAX 14® receives WHO pre-qualification, strengthening Global pn
Updated : 6 months, 1 week ago IST
Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company, announced on Thursday that its 14-valent Pneumococcal Conjugate Vaccine (PCV), PNEUBEVAX 14® (BE-PCV-14), has received World Health Organization (WHO) pre-qualification (PQ) status.
Read More
BE to manufacture HPV9 vaccine for India, UNICEF and PAHO tender markets
Updated : 10 months, 4 weeks ago IST
Jiangsu Recbio Technology Company Limited (02179.HK), announced that they have entered into a licensing cooperation agreement, and have commenced the technology transfer of their Recombinant 9-valent HPV (HPV9) vaccine, REC603, to Biological E. Limited (BE), a leading Indian vaccine and phar
Read More
Biological E Limited partners with Bavarian Nordic to increase global acce
Updated : 1 year, 3 months ago IST
Biological E Limited (BE) on Tuesday announced a strategic partnership with Bavarian Nordic A/S (OMX: BAVA) to expand access to Bavarian Nordic's Chikungunya Vaccine in low- and middle-income countries (LMIC).
Read More
Biological E receives WHO's pre-qualification status for its novel oral Po
Updated : 1 year, 10 months ago IST
Biological E Limited (BE), a Hyderabad-based vaccine and pharmaceutical company, announced on Tuesday that the World Health Organisation (WHO) has granted pre-qualification (PQ) status to their novel oral polio vaccine type 2 (nOPV2).
Read More
Takeda Accelerates Access to its Dengue Vaccine Through 'Make in India' Ma
Updated : 2 years, 2 months ago IST
Singapore, February 27: Takeda (TSE:4502/NYSE:TAK) today announced a strategic partnership with Biological E. Limited, a leading vaccines and biologics company in India, to manufacture Takeda's dengue vaccine, TAK-003. The partnership marks a crucial step in the fight against the global publ
Read More
Biological E gets DCGI's nod to manufacture, market 14-valent pneumococcal
Updated : 3 years, 5 months ago IST
Streptococcus pneumonia infection remains one of the leading causes of death among children under five in India and developing countries. BE's PCV14 Vaccine will help prevent invasive pneumococcal infection and save millions of lives worldwide. PCV14 may be administered to infants of 6, 1
Read More
Biological E announces CDSCO's recommendation of its 14-Valent Pneumococca
Updated : 3 years, 8 months ago IST
Hyderabad (Telangana) [India] September 1 (ANI): Hyderabad-based vaccines manufacturer Biological E Limited announced on Thursday that the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) reviewed and approved the Phase III infants clinical trial data
Read More
Corbevax likely to be available at vaccination centres from tomorrow
Updated : 3 years, 9 months ago IST
Hyderabad (Telangana) [India], August 11 (ANI): The recently approved heterologous Covid-19 vaccine, Corbevax is expected to be available as a booster dose on the COWIN App in both public and private vaccination centres from Friday, manufacturer Biological E. Limited (BE) said.
Read More
Corbevax approved as precaution dose for adults vaccinated with Covaxin, C
Updated : 3 years, 9 months ago IST
New Delhi [India], August 10 (ANI): Union Health Secretary Rajesh Bhushan on Wednesday said that the Centre has approved Biological E's Corbevax as a precaution dose after completion of six months from the date of administration of the second dose of either Covaxin or Covishield vaccines
Read More
CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin,
Updated : 3 years, 9 months ago IST
New Delhi [India], August 10 (ANI): The Central government has approved Biological E's Corbevax for restricted use in an emergency as a heterologous booster dose, official sources confirmed on Wednesday.
Read More
Biological E to amp up vaccine production with Rs 1,800-crore investment
Updated : 3 years, 10 months ago IST
Hyderabad (Telangana) [India], July 22 (ANI): As India is cementing Hyderabad's position as the "Vaccine Capital of the World", Biological E has announced its expansion plans for vaccine manufacturing with an overall investment of more than Rs 1,800 crore.
Read More
NTAGI to discuss data of Gennova pharmaceuticals' indigenous mRNA vaccine
Updated : 3 years, 10 months ago IST
New Delhi [India], July 11 (ANI): The National Technical Advisory Group on Immunisation (NTAGI's) Covid working group is expected to conduct a meeting soon to discuss India's first mRNA vaccine against COVID and Biological E's Corbevax Booster dose for Covishield and Covaxin beneficiaries
Read More